ES2181908T3 - Nuevas composiciones a base de una mezcla sinergetica entre al menos un ligando de vdr y un retinoide. - Google Patents

Nuevas composiciones a base de una mezcla sinergetica entre al menos un ligando de vdr y un retinoide.

Info

Publication number
ES2181908T3
ES2181908T3 ES96931100T ES96931100T ES2181908T3 ES 2181908 T3 ES2181908 T3 ES 2181908T3 ES 96931100 T ES96931100 T ES 96931100T ES 96931100 T ES96931100 T ES 96931100T ES 2181908 T3 ES2181908 T3 ES 2181908T3
Authority
ES
Spain
Prior art keywords
retinoid
compositions based
new compositions
vdr binding
synergetic mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96931100T
Other languages
English (en)
Inventor
Serge Michel
Veronique Dionisius-Pouget
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Centre International de Recherches Dermatologiques Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9482603&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2181908(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galderma Research and Development SNC, Centre International de Recherches Dermatologiques Galderma filed Critical Galderma Research and Development SNC
Application granted granted Critical
Publication of ES2181908T3 publication Critical patent/ES2181908T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

LA INVENCION SE REFIERE A UNA NUEVA ASOCIACION A BASE DE AL MENOS UN LIGANDO QUE PRESENTA UNA ACTIVIDAD SELECTIVA PARA EL RECEPTOR VDR Y DE UN RETINOIDE SELECTIVO DE LOS RECEPTORES RAR{SUB,GA} RESPECTO A LOS RECEPTORES RAR{SUB,AL}, LA UTILIZACION EN DERMATOLOGIA O EN COSMETOLOGIA DE ESTA ASOCIACION, DESTINADA A TRATAR LOS TRASTORNOS UNIDOS A UNA HIPERPROLIFERACION CELULAR, MAS EN PARTICULAR DE CELULAS DE LA PIEL, TALES COMO LA SORIASIS.
ES96931100T 1995-09-15 1996-09-10 Nuevas composiciones a base de una mezcla sinergetica entre al menos un ligando de vdr y un retinoide. Expired - Lifetime ES2181908T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9510854A FR2738745B1 (fr) 1995-09-15 1995-09-15 Nouvelles compositions a base d'un melange synergetique entre au moins un ligand de vdr et un retinoide, et leurs utilisations

Publications (1)

Publication Number Publication Date
ES2181908T3 true ES2181908T3 (es) 2003-03-01

Family

ID=9482603

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96931100T Expired - Lifetime ES2181908T3 (es) 1995-09-15 1996-09-10 Nuevas composiciones a base de una mezcla sinergetica entre al menos un ligando de vdr y un retinoide.

Country Status (14)

Country Link
US (1) US6759396B1 (es)
EP (1) EP0788361B1 (es)
JP (1) JP2898100B2 (es)
AT (1) ATE218349T1 (es)
AU (1) AU687687B2 (es)
BR (1) BR9606648B1 (es)
CA (1) CA2204437C (es)
DE (1) DE69621580T2 (es)
DK (1) DK0788361T3 (es)
ES (1) ES2181908T3 (es)
FR (1) FR2738745B1 (es)
NZ (1) NZ318430A (es)
PT (1) PT788361E (es)
WO (1) WO1997009987A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6538037B2 (en) * 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US6552009B2 (en) 1998-07-16 2003-04-22 Gentrix Llc Compositions and methods of treating abnormal cell proliferation
US20010002396A1 (en) 1998-07-16 2001-05-31 Charles Achkar Compositions and methods of treating skin conditions
FR2804323B1 (fr) * 2000-01-31 2006-07-07 Galderma Res & Dev Utilisation de composes de type retinoides en tant qu'agents anti-bacteriens
DE10255861A1 (de) * 2002-11-29 2004-06-17 Axxima Pharmaceuticals Ag Gegen Hepatitis C-Virusinfektionen nützliche Verbindungen und Substanzen
JP4473491B2 (ja) * 2002-05-28 2010-06-02 株式会社資生堂 毛穴縮小剤
WO2005051893A2 (en) * 2003-11-20 2005-06-09 Eli Lilly And Company Vitamin d receptor modulators
US7750184B2 (en) * 2003-11-20 2010-07-06 Eli Lilly And Company Vitamin D receptor modulators
WO2005102296A2 (en) * 2004-04-23 2005-11-03 Heptagen Limited Combinations for the treatment of immunoproliferative skin disorders such as psoriasis
FR2871700B1 (fr) * 2004-06-17 2006-11-17 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
MXPA06014397A (es) * 2004-06-17 2007-02-15 Galderma Sa Composicion en forma de aerosol que comprende una combinacion de un corticoide y un derivado de la vitamina d en una fase aceitosa.
FR2871695B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un agent silicone et deux principes actifs solubilises
FR2871698B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
AU2005253735A1 (en) * 2004-06-17 2005-12-29 Galderma S.A. Composition for the treatment of psoriasis comprising a silicone agent, a corticosteroid and vitamin D or a derivative thereof
DE602005003138T3 (de) * 2004-06-17 2011-07-14 Galderma S.A. Zusammensetzung in sprayform mit einer kombination aus clobetasolpropionat und calcitriol, einer alkoholphase und ölphase
WO2006133829A2 (de) * 2005-06-17 2006-12-21 Dsm Ip Assets B.V. Verwendung von 25-hydroxy-vitamin d3
WO2008065514A2 (en) * 2006-11-29 2008-06-05 Glenmark Pharmaceuticals Limited Pharmaceutical compositions containing anhydrous calcipotriene
CN103202821B (zh) * 2013-04-09 2014-10-01 青岛正大海尔制药有限公司 一种骨化三醇软胶囊及其制备方法
KR102406880B1 (ko) 2015-10-30 2022-06-08 팀버 파마슈티칼스 엘엘씨 이소트레티노인 제형 및 이의 용도 및 사용 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85849A1 (fr) * 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
US5780676A (en) * 1992-04-22 1998-07-14 Ligand Pharmaceuticals Incorporated Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
FR2713635B1 (fr) 1993-12-15 1996-01-05 Cird Galderma Nouveaux composés propynyl bi-aromatiques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
FR2713640B1 (fr) * 1993-12-15 1996-01-05 Cird Galderma Nouveaux composés aromatiques polycycliques, compositions pharmaceutiques et cosmétiques les contenant et utilisations.
FR2733684B1 (fr) * 1995-05-03 1997-05-30 Cird Galderma Utilisation de retinoides dans une composition cosmetique ou pour la fabrication d'une composition pharmaceutique

Also Published As

Publication number Publication date
FR2738745A1 (fr) 1997-03-21
US6759396B1 (en) 2004-07-06
PT788361E (pt) 2002-11-29
DE69621580D1 (de) 2002-07-11
JP2898100B2 (ja) 1999-05-31
EP0788361B1 (fr) 2002-06-05
CA2204437C (fr) 2003-06-10
DE69621580T2 (de) 2003-03-13
ATE218349T1 (de) 2002-06-15
MX9703461A (es) 1997-07-31
WO1997009987A1 (fr) 1997-03-20
DK0788361T3 (da) 2002-07-15
FR2738745B1 (fr) 1997-10-24
JPH10503533A (ja) 1998-03-31
BR9606648A (pt) 1997-09-16
CA2204437A1 (fr) 1997-03-20
BR9606648B1 (pt) 2009-01-13
EP0788361A1 (fr) 1997-08-13
AU6991296A (en) 1997-04-01
AU687687B2 (en) 1998-02-26
NZ318430A (en) 2000-09-29

Similar Documents

Publication Publication Date Title
ES2181908T3 (es) Nuevas composiciones a base de una mezcla sinergetica entre al menos un ligando de vdr y un retinoide.
DE69720978D1 (de) Topische mittel, die eine öl-in-wasser emulsion und ein retinoid enthalten
BR9809465A (pt) Composições de cuidados com a pele e método para melhorar a aparência da pele
RU2003102634A (ru) Композиция для кондиционирования кожи, содержащие соединения, имитирующие действие ретиноевой кислоты на кожу
BR9407924A (pt) Corpo revestido processo para sua fabricaçao assim como emprego do mesmo
ATE209032T1 (de) Retinoid-formulierungen in porösen mikrokugeln für verringerte irritation und verbesserte stabilität
FI102142B (fi) Kosmeettinen koostumus, joka käsittää vähintään yhtä aktiivista ainett a sisältäviä, polymeerista tai rasvasta valmistettuja mikropalloja
FI953743A0 (fi) Keratolyyttistä ja/tai finnitaudinvastaista aktiivisuutta omaavia kosmeettisia koostumuksia, niiden valmistus ja käyttö
ATE197893T1 (de) Zahnpflegemitteln
DE60124307D1 (de) Hautpflegemittel enthaltend retinoide und phytoöstrogene in einem doppelkammer-behältnis
MXPA03005931A (es) Composiciones estables para el cuidado de la piel conteniendo un retinoide y un sistema reforzador de retinoides.
MX9704948A (es) Retinoides triciclicos, metodos para su produccion y uso.
Morelli et al. Contact dermatitis due to benzoyl peroxide.
FR2718640B1 (fr) Composition cosmétique et/ou dermatologique notamment pour dépigmenter la peau, ses utilisations.
ES2152959T3 (es) Utilizacion en perfumeria de isomeros opticamente activos del (e)-3,3-dimetil-5-(2,2,3-trimetil-3-ciclopenten-1-il)-4-penten-2-ol.
DE69323191D1 (de) Wasserlösliche retinoide
DE69718168D1 (de) Zusammensetzungen enthaltend vx478, zidovudine und 159u89 für die verwendung in der behandlung von hiv
DE59803222D1 (de) Kosmetische mittel
DE68900127D1 (de) Laktonmodifizierte dispergierzusaetze, verwendbar in oeligen zusammensetzungen.
KR960020986A (ko) 두발화장품 조성물
KR890006806A (ko) 약쑥(애엽)분말이 함유된 피부보호 미용 비누 제조 방법
RU94008830A (ru) Основа для косметических средств
TH28890A (th) องค์ประกอบของสารที่ใช้ดูแลรักษาผิวหนังที่มีกรดและเรตินอยด์อยู่
RO117669B1 (ro) Loţiune pentru regenerarea şi hidratarea părului
IT240125Y1 (it) Lavandino con bide' sottostante estraibile, disposti in modo daformare una struttura compatta.